GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » Days Payable

Intravenous Infusions (XGHA:IIL) Days Payable : 0.00 (As of . 20)


View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions Days Payable?

Intravenous Infusions's average Accounts Payable for the six months ended in . 20 was GHS0.00 Mil. Intravenous Infusions's Cost of Goods Sold for the six months ended in . 20 was GHS0.00 Mil.

The historical rank and industry rank for Intravenous Infusions's Days Payable or its related term are showing as below:

XGHA:IIL's Days Payable is not ranked *
in the Drug Manufacturers industry.
Industry Median: 86.34
* Ranked among companies with meaningful Days Payable only.

Intravenous Infusions's Days Payable stayed the same from . 20 (0.00) to . 20 (0.00).


Intravenous Infusions Days Payable Historical Data

The historical data trend for Intravenous Infusions's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions Days Payable Chart

Intravenous Infusions Annual Data
Trend
Days Payable

Intravenous Infusions Semi-Annual Data
Days Payable

Competitive Comparison of Intravenous Infusions's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Intravenous Infusions's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intravenous Infusions's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intravenous Infusions's Days Payable distribution charts can be found below:

* The bar in red indicates where Intravenous Infusions's Days Payable falls into.



Intravenous Infusions Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Intravenous Infusions's Days Payable for the fiscal year that ended in . 20 is calculated as

Days Payable (A: . 20 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: . 20 ) + Accounts Payable (A: . 20 )) / count ) / Cost of Goods Sold (A: . 20 )*Days in Period
=( ( + ) / 1 ) / *365
=0 / *365
=N/A

Intravenous Infusions's Days Payable for the quarter that ended in . 20 is calculated as:

Days Payable (Q: . 20 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: . 20 ) + Accounts Payable (Q: . 20 )) / count ) / Cost of Goods Sold (Q: . 20 )*Days in Period
=( ( + ) / 1 ) / *365 / 2
=0 / *365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Intravenous Infusions Days Payable Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Intravenous Infusions Business Description

Traded in Other Exchanges
N/A
Address
Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.